About Conolidine Proleviate for Joint Pain Treatment
Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors within the central nervous technique, conolidine modulates alternate molecular targets. A Science Advances study identified that conolidine interacts While using the atypical chemokine receptor ACKR3/C